A carregar...

Real-world evaluation of compliance and preference in Alzheimer’s disease treatment: an observational study in Taiwan

PURPOSE: Among the medications approved for Alzheimer’s disease (AD), rivastigmine is the only one available as transdermal patch. The aim of this study was to evaluate compliance and caregivers’ preference with oral and transdermal (rivastigmine) monotherapy in patients with mild-to-moderate AD fro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Patient Prefer Adherence
Main Authors: Lai, Tzu-Hsien, Wang, Wen-Fu, Yip, Bak-Sau, Yang, Yu-Wan, Peng, Giia-Sheun, Tsai, Shih-Jei, Liao, Yi-Chu, Pai, Ming-Chyi
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4821393/
https://ncbi.nlm.nih.gov/pubmed/27099476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S95271
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!